Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Thursday, September 25, 2014

VistaGen Therapeutics, Inc. (VSTA) Sees AV-101 as Potential...

September 25, 2014 It's one of the single most sought-after drugs in the medical industry, and biotechnology company VistaGen Therapeutics may have it. What is so desperately needed is a drug able to treat a disease that afflicts tens of millions of people in the U.S., and hundreds of millions globally.

http://ift.tt/YeTyID

No comments:

Post a Comment

Popular Stem Cell Roundup Posts